L-DOPA treatment modulates nicotinic receptors in monkey striatum

Molecular Pharmacology

Volumn 64, Issue 3, 2003, Pages 619-628

  Quik, Maryka ^a   Bordia, Tanuja ^a   Okihara, Michaella ^a   Fan, Hong ^c   Marks, Michael J ^b   McIntosh, J Michael ^d   Whiteaker, Paul ^b  

^a PARKINSON S INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; CHOLINERGIC RECEPTOR; EPIBATIDINE; LEVODOPA; NICOTINIC RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EVOKED RESPONSE; INTERNEURON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION;

ANIMALS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; LEVODOPA; MALE; MPTP POISONING; PROTEIN BINDING; RECEPTORS, NICOTINIC; SAIMIRI;

EID: 0041854335     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.3.619     Document Type: Article

References (41)

1. Arroyo-Jimenez MM, Bourgeois JP, Marubio LM, Le Sourd AM, Ottersen OP, Rinvik E, Fairen A, and Changeux JP (1999) Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra. J Neurosci 19:6475-6487.
2. Barnes NM and Sharp T (1999) A review of central 5-HT receptors and their function, Neuropharmacology 38:1083-1152.
3. Bezard E, Brotchie JM, and Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2:577-588.
4. Champtiaux N, Han ZY, Bessis A, Rossi FM, Zoli M, Marubio L, McIntosh JM, and Changeux JP (2002) Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 22:1208-1217.
5. Cheng YC and Prusoff WH (1974) A new rapid assay for measuring deoxycytidylateand deoxythymidylate-kinase activities. Anal Biochem 60:545-550.
6. Clarke PB and Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358.
7. Collins AC, Luo Y, Selvaag S, and Marks MJ (1994) Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther 271:125-133.
8. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, and Perry EK (2000) Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience 98:79-87.
9. Desce JM, Godeheu G, Galli T, Artaud F, Cheramy A, and Glowinski J (1991) Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl·4-isoxazole propionate receptors on synaptosomes from the rat striatum. J Pharmacol Exp Ther 259:692-698.
10. Fearnley JM and Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283-2301.
11. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41: 31-37.
12. Gerfen CR (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci 23:S64-S70.
13. Grady SR, Meinerz NM, Cao J, Reynolds AM, Picciotto MR, Changeux JP, McIntosh JM, Marks MJ, and Collins AC (2001) Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem 76:258-268.
14. Han ZY, Le Novere N, Zoli M, Hill JA Jr, Champtiaux N, and Changeux JP (2000) Localization of nAChR subunit mRNAs in the brain of Macaca mulatta. Eur J Neurosci 12:3664-3674.
15. Jones IW, Bolam JP, and Wonnacott S (2001) Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones. J Comp Neurol 439:235-247.
16. Kemel ML, Desban M, Glowinski J, and Gauchy C (1989) Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc Natl Acad Sci USA 86:9006-9010.
17. Klink R, de Kerchove d'Exaerde A, Zoli M, and Changeux JP (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452-1463.
18. Kulak JM, McIntosh JM, and Quik M (2002a) Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites. Mol Pharmacol 61:230-238.
19. Kulak JM, Musachio JL, McIntosh JM, and Quik M (2002b) Declines in different β2* containing nicotinic receptor populations in monkey striatum after nigrostriatal damage. J Pharmacol Exp Ther 303:633-639.
20. Langston JW, Quik M, Petzinger G, Jakowec M, and Di Monte DA (2000) Investigating levodopa-induced dyskinesias in the parkinsonian primate. Ann Neurol 47:S79-S89.
21. Le Novere N, Zoli M, and Changeux JP (1996) Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8:2428-2439.
22. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, et al. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51:397-401.
23. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, and Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784.
24. Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bedard PJ, and Di Paolo T (1996) Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Mol Pharmacol 50: 1073-1079.
25. Musachio JL, Villemagne VL, Scheffel UA, Dannals RF, Dogan AS, Yokoi F, and Wong DF (1999) Synthesis of an 1-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon. Nucl Med Biol 26:201-207.
26. Parent A, Sato F, Wu Y, Gauthier J, Levesque M, and Parent M (2000) Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 23:S20-S27.
27. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, and Kellar KJ (2002) Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82: 468-481.
28. Quik M, Polonskaya Y, Gillespie A, Jakowec M, Lloyd GK, and Langston JW (2000) Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J Comp Neurol 425:58-69.
29. 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey. J Neurosci 21:5494-5500.
30. Quik M and Kulak JM (2002) Nicotine and nicotinic receptors; relevance to Parkinson's disease. Neurotoxicology 131:1-14.
31. Quik M, Sum JD, Whiteaker P, McCallum SE, Marks MJ, Musachio JM, McIntosh JM, Collins AC, and Grady SR (2003) Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice. Mol Pharmacol 63:1169-1179.
32. Rioux L, Frohna PA, Joyce JN, and Schneider JS (1997) The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Mov Disord 12:148-158.
33. 3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J Neurochem 32:1539-1545.
34. Rowell PP and Wonnacott S (1990) Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J Neurochem 55:2105-2110.
35. 3H] acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427-433.
36. 3H] acetylcholine on catecholaniine and serotonin axons in brain. J Neurochem 42:1495-1498.
37. 125I]-epibatidine. Br J Pharmacol 131:729-739.
38. Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AL, Collins AC, and Marks MJ (2002) Involvement of the alpha3 subunit in central nicotinic binding populations. J Neurosci 22:2522-2529.
39. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98.
40. Zhou FM, Liang Y, and Dani JA (2001) Endogenous nicotinic cholmergic activity regulates dopamine release in the striatum. Nat Neurosci 4:1224-1229.
41. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, and Gotti C (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22:8785-8789.